TransCode Therapeutics ( ($RNAZ) ) just unveiled an update. On January 6, 2026, TransCode Therapeutics announced the publication in the Journal of ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancer, today announced the ...
TTX-MC138 is delivered to glioblastoma tumors in murine models of the disease, following intravenous injection TTX-MC138 demonstrated suppression of miR-10b target and extended survival in aggressive ...
BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced today that its lead therapeutic candidate, TTX-MC138, demonstrated efficacy in preclinical models of glioblastoma multiforme (GBM), the ...
Investing.com -- TransCode Therapeutics (NASDAQ:RNAZ) stock surged 18% on Tuesday after the company published preclinical data showing its lead candidate TTX-MC138 demonstrated therapeutic potential ...
Publishes Preclinical Data Supporting TTX-MC138 For Glioblastoma. TransCode Therapeutics (NASDAQ: RNAZ) announced the publication of peer-reviewed preclinical research supporting the use of its lead ...
TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company’s lead therapeutic candidate ...
UNIONDALE, NY / ACCESS Newswire / January 6, 2026 / Marquis Who's Who honors Jason A. Marks, MBA-HCM, for his expertise in ...
XDA Developers on MSN
Stop buying Raspberry Pis for Plex/Jellyfin — get a used office PC instead
Take the Raspberry Pi family, for instance. While you could deploy Plex or Jellyfin on most Single-Board Computers in the RPi ...
A new report on the consumer health industry has found the COVID-19 aftermath has largely worn off, and forward progress is emerging again. This is headlined by a growing focus on healthy aging ? a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback